(E)-2-(3-fluoro-8-formyldibenzo[b,e]oxepin-11(6H)-ylidene)propanenitrile → HCID 86721455, compound
Reaction equation
[Br:1][C:2]1[CH:7]=[CH:6][N:5]2[C:8](I)=[C:9]([CH:11]3[CH2:13][CH2:12]3)[N:10]=[C:4]2[CH:3]=1.[F:15][C:16]1[CH:17]=[CH:18][C:19]2=[C:20]([CH:36]=1)[O:21][CH2:22][C:23]1[CH:33]=[C:32]([CH:34]=[O:35])[CH:31]=[CH:30][C:24]=1/[C:25]/2=[C:26](/[CH3:29])\[C:27]#[N:28]>>[Br:1][C:2]1[CH:7]=[CH:6][N:5]2[C:8]([CH:34]([OH:35])[C:32]3[CH:31]=[CH:30][C:24]4/[C:25](=[C:26](/[CH3:29])\[C:27]#[N:28])/[C:19]5[CH:18]=[CH:17][C:16]([F:15])=[CH:36][C:20]=5[O:21][CH2:22][C:23]=4[CH:33]=3)=[C:9]([CH:11]3[CH2:13][CH2:12]3)[N:10]=[C:4]2[CH:3]=1Participants
3
Procedure
[step 3] Using 7-bromo-2-cyclopropyl-3-iodoimidazo[1,2-a]pyridine (4.6 g, 13 mmol) obtained in step 2 and (E)-2-(3-fluoro-8-formyldibenzo[b,e]oxepin-11(6H)-ylidene)propanenitrile (2.3 g, 7.9 mmol) obtained in Reference Example 5, and in the same manner as in Reference Example 14A, step 3, (E)-2-{8-[(7-bromo-2-cyclopropylimidazo[1,2-a]pyridin-3-yl)(hydroxy)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene}propanenitrile (4.1 g, 98%) was obtained.
Workup
- customobtained in Reference Example 5
Sources & evidence
- ORD record
- ord-0a3f1284834f4ae9a87a5aeff8d09b06
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08969345B2
Reaction notes
Loading…